DFO-BCN

CAT: 0804-HY-170749Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-170749Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DFO-BCN is a drug intermediate, that can be used for synthesis of PET/CT imaging agent DFO-CPC634 through click chemistry[1].
CAS Number
[2910882-32-3]
UNSPSC
12352203
Target
Drug Intermediate
Related Pathways
Others
Field of Research
Others
Smiles
CC(N(O)CCCCCNC(CCC(N(O)CCCCCNC(CCC(N(O)CCCCCNC(OC[C@@H]1[C@@]2([H])[C@]1([H])CCC#CCC2)=O)=O)=O)=O)=O)=O
Molecular Formula
C36H60N6O10
Molecular Weight
736.90
References & Citations
[1]Miedema IHC, et al., PET-CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients. Adv Mater. 2022 May;34 (21) :e2201043.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported

Related Products

CatalogName
HY-173390BCN-E-BCN
HY-164590BCN-NODAGA
HY-148880-01VHLL-BCN
HY-164574-01BCN-DOTA
HY-W111141-01BCN-OH
HY-D2214SiR-PEG4-BCN
HY-D3059BCN-PEG2000-Rhodamine
HY-130924-01BCN-PEG3-Biotin
HY-130926BCN-PEG3-oxyamine
HY-130925-01BCN-PEG3-OH

Alternative Products

CatalogName
S6849-250mgDFO
MBS5779941BCN-E-BCN
IA-0012Desferrioxamine (DFO) solution (1000x)
MD253253-2endo-BCN-PEG2-endo-BCN
70540-AATCy3 BCN
70604-AATXFD532 BCN
70607-AATXFD568 BCN
70608-AATXFD594 BCN
70610-AATXFD680 BCN
70613-AATXFD790 BCN

Popular Products